Vietnam is currently witnessing a transformative "Decade of Genomics." As the country accelerates its healthcare modernization, the demand for precision diagnostics—specifically DNA analysis systems—has moved from high-end research facilities to provincial hospitals and private diagnostic chains. From Ho Chi Minh City to Hanoi, the surge in genetic screening for non-communicable diseases, prenatal testing (NIPT), and infectious disease monitoring has positioned Vietnam as a critical hub for biotechnology in Southeast Asia.
As a leading factory and supplier, we recognize that the Vietnam market requires more than just equipment; it requires robust, climate-resilient, and cost-effective molecular solutions. The transition from traditional biochemical testing to molecular-level analysis necessitates high-throughput PCR detection systems, advanced gel documentation, and ultra-pure water systems that can withstand the tropical environmental challenges while meeting international ISO and CE standards.
Annual Growth in Vietnam Biotech Market
State-of-the-Art Manufacturing Facility
Expert Scientists & Engineers
Compliance (CE, ISO 13485)
The global roadmap for DNA analysis is shifting toward Automation and Integration. Our current R&D focuses on the "Sample-to-Result" workflow. In Vietnam, where laboratory labor costs are rising and the need for standardization is paramount, we provide systems that minimize human intervention, thereby reducing contamination risks in PCR and electrophoresis processes.
Vietnam’s high humidity levels can significantly affect the lifespan of optical sensors in Gel Imaging Systems. Our Vietnam-market-specific configurations include enhanced moisture-sealing for HD cameras and gold-plated connectors for electrophoresis power supplies to ensure 24/7 reliability in sub-tropical climates.
The future of DNA analysis lies in data. Our imaging systems now support USB 3.0 interfaces and cloud-compatible software, allowing researchers in Vietnamese universities to share gel documentation results with global collaborators in real-time. We are integrating AI-driven band detection to remove subjectivity from protein and nucleic acid analysis.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific (with a focus on the Vietnam market), the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
Navigating the regulatory landscape in Vietnam requires a partner who understands the Department of Medical Equipment and Construction (DMEC) under the Ministry of Health (MOH). BioX Medical provides full documentation support for Class A, B, and C medical device registrations in Vietnam.
Our imaging systems feature hermetically sealed optical chambers and anti-fungal coatings on lenses. We also recommend our Ultra-Pure Water systems to prevent mineral buildup in sensitive components.
Yes, we offer full OEM services including custom software branding, hardware modifications, and specialized packaging for local distributors in Vietnam.
Standard orders typically ship within 7-14 days. Logistics to major Vietnamese ports takes approximately 5-10 days via sea freight or 2 days via air freight from Shenzhen.
Our systems utilize open-platform technology, making them compatible with major international and Vietnamese-developed reagents and PCR kits.
BioX Medical
